Pharma Journalist -

MustGrow Biologics Corp. and Bayer have signed an Exclusive Agreement to evaluate MustGrow's biological technologies to determine efficacy and commercial potential in key agricultural…
Read More...

Colorcon Ventures, the corporate venture fund of Colorcon Inc., has invested in Apprentice.io, a leading provider of Intelligent Manufacturing Execution Systems (MES) designed…
Read More...

Nuvation Bio Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application to evaluate NUV-868, a BD2-selective oral small…
Read More...

Senhwa Biosciences, Inc. a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, announced that the US Food and Drug…
Read More...

Bristol-Myers Squibb K.K. announced that Japan’s Ministry of Health, Labour and Welfare has approved Abecma (idecabtagene vicleucel), a B-cell maturation antigen (BCMA)-directed…
Read More...

Syapse announced that Pfizer will continue working with Syapse to advance the use of real-world data (RWD) from the Syapse Learning Health Network (LHN), as an extension of the…
Read More...

Selexis SA, a JSR Life Sciences company, and Inotrem SA, an advanced clinical-stage biotech company specialized in immunotherapies for acute and chronic inflammatory syndromes, have…
Read More...

UCB and Zogenix announced that the companies have entered into a definitive agreement under which UCB would acquire Zogenix, Inc., a global biopharmaceutical company commercializing and…
Read More...

Xcell Biosciences, Inc. (“Xcellbio”), a leading developer of innovative technologies and platforms designed to further the research, development, and manufacturing of cell and gene…
Read More...